EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

KMT2D deficiency leads to cellular developmental disorders and enhancer dysregulation in neural-crest-containing brain organoids

Ziyun Shan, Yingying Zhao, Xiuyu Chen, Guodong Zhan, Junju Huang, Xuejie Yang, Chongshen Xu, Ning Guo, Zhi Xiong, Fang Wu, Yujian Liu, He Liu und 13 weitere

Science Bulletin · 2024

DOI: 10.1016/j.scib.2024.09.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Bulletin, 2024. Verfasst von Ziyun Shan und 24 weiteren Autor:innen. Beteiligte Einrichtung: Center for Cell Lineage and Development, Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, Guangdong-Hong Kong Joint Labora…. Hauptthemen laut MEDLINE: Organoids, Neural Crest, Vestibular Diseases, Brain. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Youth Innovation Promotion Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

KMT2D, a H3K4me1 methyltransferase primarily regulating enhancers, is a leading cause of KABUKI syndrome. This multisystem disorder leads to craniofacial and cognitive abnormalities, possibly through neural crest and neuronal lineages. However, the impacted cell-of-origin and molecular mechanism of KMT2D during the development of KABUKI disease remains unknown. Here we have optimized a brain organoid model to investigate neural crest and neuronal differentiation. To pinpoint KMT2D's enhancer target, we developed a genome-wide cis-regulatory element explorer (GREE) based on single-cell multiomic integration. Single cell RNA-seq revealed that KMT2D-knockout (KO) and patient-derived organoids exhibited neural crest deformities and GABAergic overproduction. Mechanistically, GREE identified that KMT2D targets a roof-plate-like niche cell and activates the niche cell-specific WNT3A enhancer, providing the microenvironment for neural crest and neuronal development. Interestingly, KMT2D-mutated mice displayed decreased WNT3A expression in the diencephalon roof plate, indicating impaired niche cell function. Deleting the WNT3A enhancer in the organoids presented phenotypic similarities to KMT2D-depletion, emphasizing the WNT3A enhancer as the predominant target of KMT2D. Conversely, reactivating WNT signaling in KMT2D-KO rescued the lineage defects by restoring the microenvironment. Overall, our discovery of KMT2D's primary target provides insights for reconciling complex phenotypes of KABUKI syndrome and establishes a new paradigm for dissecting the mechanisms of genetic disorders from genotype to phenotype.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OrganoidsNeural CrestVestibular DiseasesBrainAbnormalities, MultipleAnimalsMiceHumansFaceEnhancer Elements, GeneticMice, KnockoutHematologic DiseasesDNA-Binding ProteinsHistone-Lysine N-MethyltransferaseNeoplasm ProteinsCell DifferentiationNeurogenesisNeuronsMyeloid-Lymphoid Leukemia Protein

Stichwörter der Autor:innen

Cerebral organoidsEnhancerKMT2DNicheSingle-cell multiome

Substanzen

Kmt2d protein, mouseKMT2D protein, humanDNA-Binding ProteinsHistone-Lysine N-MethyltransferaseNeoplasm ProteinsMyeloid-Lymphoid Leukemia Protein

Autor:innen und Institutionen

  • Center for Cell Lineage and Development, Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, Guangdong-Hong Kong Joint Laboratory for Stem Cell and Regenerative Medicine, Guangzhou Institutes of…
  • Child Development and Behavior Center, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou 510630, China.
  • Center for Cell Lineage and Atlas (CCLA), Bioland Laboratory, Guangzhou 510005, China; The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou 510700, China.
  • Guangzhou Laboratory, Guangzhou 510005, China.
  • Center for Cell Lineage and Atlas (CCLA), Bioland Laboratory, Guangzhou 510005, China; Guangzhou Laboratory, Guangzhou 510005, China.
  • Center for Cell Lineage and Atlas (CCLA), Bioland Laboratory, Guangzhou 510005, China.

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Youth Innovation Promotion Association
  • Ministry of Science and Technology of the People's Republic of China
  • Zhejiang University
  • Institute of Genetics and Developmental Biology, Chinese Academy of Sciences
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • Biofyzikální Ústav, Akademie Věd České Republiky

Zitieren

APA

Shan, Z., Zhao, Y., Chen, X., Zhan, G., Huang, J., Yang, X., Xu, C., Guo, N., Xiong, Z., Wu, F., Liu, Y., Liu, H., Chen, B., Chen, B., Sun, J., He, J., Guo, Y., Cao, S., Wu, K., …, & Chen, J. (2024). KMT2D deficiency leads to cellular developmental disorders and enhancer dysregulation in neural-crest-containing brain organoids. Science Bulletin. https://doi.org/10.1016/j.scib.2024.09.004

Vancouver

Shan Z, Zhao Y, Chen X, Zhan G, Huang J, Yang X, et al. KMT2D deficiency leads to cellular developmental disorders and enhancer dysregulation in neural-crest-containing brain organoids. Science Bulletin. 2024. doi:10.1016/j.scib.2024.09.004

BibTeX
@article{Shan2024,
  author = {Shan, Ziyun and Zhao, Yingying and Chen, Xiuyu and Zhan, Guodong and Huang, Junju and Yang, Xuejie and Xu, Chongshen and Guo, Ning and Xiong, Zhi and Wu, Fang and Liu, Yujian and Liu, He and Chen, Biyuan and Chen, Bingqiu and Sun, Jiaoyang and He, Jiangping and Guo, Yiping and Cao, Shangtao and Wu, Kaixin and Mao, Rui and Wu, Guangming and Lin, Lihui and Zou, Xiaobing and Wang, Jie and Chen, Jiekai},
  title = {KMT2D deficiency leads to cellular developmental disorders and enhancer dysregulation in neural-crest-containing brain organoids},
  journal = {Science Bulletin},
  year = {2024},
  doi = {10.1016/j.scib.2024.09.004}
}
Kostenlos starten →